The questions started pouring into adolescent medicine specialist Hina Talib’s inbox almost as soon as
A vaccine for nearly all school-age children could become available by the end of October, after Pfizer and its partner BioNTech SE announced they sent initial data to the Food and Drug Administration about the use of their Covid-19 vaccine in children ages 5 to 11. It is the only vaccine that’s fully approved for everyone 16 and up, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.